Donate

Media center

At PATH, our global health experts are developing partnerships, new devices, and solutions to the world's most pressing health needs. Contact us to speak with one of PATH's experts today.

Contact Us

Senior Director of Marketing & Communications:
Lauren Grella

Email: media@path.org

PATH is advancing health equity around the world

December 19, 2025
The appeal of a dual-parasite combination vaccine
December 19, 2025
The future looks bright for malaria prevention
December 4, 2025
Disease outbreak survivors are key to future preparedness

Featured Press Coverage

April 18, 2024
Millions of Girls in Africa Will Miss HPV Shots After Merck Production Problem
The New York Times
November 19, 2025
Can AI safely support mental health?
Devex
February 12, 2024
Could new vaccines end malaria in Africa?
Al Jazeera

Recent Press Coverage

  1. PATH launches landmark AI study in Africa exploring LLMs’ potential in health diagnoses
    The Seattle-based global health nonprofit is deploying large-language model (LLM) technology at clinics in Nairobi to analyze patient symptoms, health histories, provider notes and lab results, and then assist with diagnosis and treatment planning.
    Published: July 2025
  2. ‘We will go on’: Global health nonprofit PATH navigates U.S. funding freeze from new Seattle HQ
    GeekWire's Lisa Stiffler attended the ribbon cutting ceremony for PATH's new Seattle office, toured PATH's engineering and biosafety labs, and spoke with experts and leaders.
    Published: June 2025
  3. The looming antibiotic emergency and why the time for global action is now
    PATH’s Nikolaj Gilbert and Dame Sally Davies write in The Telegraph about drug-resistant infections that are outpacing our ability to treat them—and how the global community must come together to address this growing global threat.
    Published: March 2025
  4. PATH part of $12.7M GHIT Fund initiative for malaria, NTDs research.
    PATH is among the global partners receiving funding from the GHIT Fund’s $12.7 million investment to advance new diagnostics and drug development for malaria and neglected tropical diseases (NTDs).
    Published: January 2025
Previous
Next

We develop evidence-based expertise and resources

Our global team leverages data and evidence to develop resources and innovations that bring good health to more people.

Explore our evidence

Join the latest discussions on health equity.

We partner with the public and private sector, government, and academia from around the world to share insightful conversations on the latest topics affecting health equity.

Explore PATH events

PATH Newsroom

Related articles

Read our latest

989 Item s
989 Item s
    Date
    From
    To
  1. Join PATH and the HepC3P project at the 14th International Conference on Health and Hepatitis in Substance Users
    At the 14th International Conference on Health and Hepatitis in Substance Users, PATH will highlight our work introducing innovative Hepatitis C virus prevention products and approaches, as well as roadmaps for advancing essential harm reduction services globally.
    Published: September 2026
    Press Release
  2. PATH and Global Fund take stock of antimalarial efficacy studies
    The Global Fund to Fight AIDS, Tuberculosis, and Malaria selects PATH to landscape, assess, and support antimalarial therapeutic efficacy studies across Sub-Saharan Africa.
    Published: September 2026
    Announcement
  3. PATH selected to lead Global Fund Integrated Surveillance grant
    The Global Fund to Fight AIDS, Tuberculosis and Malaria selects PATH to lead the Sustainable and Integrated Data Systems grant to support integration efforts in Zambia, Senegal, and Ghana.
    Published: September 2026
    Announcement
  4. PATH appoints Dr. Jeremy Farrar as Chief of Asia, Middle East, and Europe regional division
    Published: September 2026
    Press Release
  5. New SARS-CoV-1 antibody available for vaccine researchers
    Targeted antibodies can speed the development and testing of vaccines globally.
    Published: September 2026
    Press Release
Next